Vendor, College Station, TX
KJ Biosciences LLC
UEI SU7NFMFB9966, CAGE 5WYA2
1 award and -$28,081 obligated between August 22, 2024 and August 22, 2024, 100% under full and open competition, against 5.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | -$28,081 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition After Exclusion of Sources | 1 |
| Small Business Set Aside - Total | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N93019C00029Definitive Contract, August 22, 2024, Full and Open Competition After Exclusion of Sources, 5 offers | National Institutes of Health NiaidNational Institutes of Health | SBIR Phase II - Advanced Development of a Novel Nanoparticle Conjugate for Salmonella Paratyphi aNAICS 541714, PSC AN12 | -$28,081 |
- Places of performance
- Texas
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied Research
- Transactions
- 1 across 1 awards